Showing results (41-50 of 63) with videos related to
Sort By:
Pageof 7
Psychopathology|January 14, 2011
Unexplained somatic symptoms during major depression: prevalence and clinical impact in a national sample of Italian psychiatric outpatientsGiulio Perugi, Pier Luigi Canonico, Paolo Carbonato, et al.Annals of General Psychiatry|December 28, 2024
Effectiveness of a social cognition remediation intervention for patients with schizophrenia: a randomized-controlled studyLuigi Giuliani, Pasquale Pezzella, Armida Mucci, et al.Frontiers in Psychiatry|July 17, 2020
Expert Opinions and Consensus Recommendations for the Evaluation and Management of Insomnia in Clinical Practice: Joint Statements of Five Italian Scientific SocietiesLaura Palagini, Raffaele Manni, Eugenio Aguglia, et al.Rivista Di Psichiatria|December 22, 2020
[Evaluation and management of insomnia in clinical practice and in the time of CoViD-19 in Italy: expert consensus and task-force recommendations from five scientific societies]Laura Palagini, Raffaele Manni, Eugenio Aguglia, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 25, 2011
A mono-institutional prospective study on the effectiveness of a specialist psychotherapeutic intervention (POI) started at the diagnosis of cancerChristian Lurati, Marco Riva, Roberta Resega, et al.Neuropsychiatric Disease and Treatment|May 17, 2011
Prevalence and diagnostic distribution of medically unexplained painful somatic symptoms across 571 major depressed outpatientsMichele Fornaro, Icro Maremmani, Pier Luigi Canonico, et al.Archives of Women'S Mental Health|April 14, 2022
Insomnia evaluation and treatment during peripartum: a joint position paper from the European Insomnia Network task force "Sleep and Women," the Italian Marcè Society and international experts task force for perinatal mental healthLaura Palagini, Alessandra Bramante, Chiara Baglioni, et al.Clinical Therapeutics|January 30, 2010
Effects of treatment with etizolam 0.5 mg BID on cognitive performance: a 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorderMaria Pia De Candia, Guido Di Sciascio, Federico Durbano, et al.BMC Psychiatry|March 26, 2013
Compliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA studyPaolo A Cortesi, Claudio Mencacci, Ferrannini Luigi, et al.Psychopathology|August 15, 2012
Discriminative hypomania checklist-32 factors in unipolar and bipolar major depressive patientsGiulio Perugi, Michele Fornaro, Icro Maremmani, et al.Pageof 7